61
|
222
|
5l5iL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
65
|
211
|
5l5sK |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
71
|
244
|
5l5pB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
70
|
243
|
5l55F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
62
|
231
|
5l5qE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
69
|
240
|
5l5jC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
71
|
243
|
5l5sF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
71
|
243
|
5l52F |
Yeast 20s proteasome in complex with epoxyketone inhibitor 14 |
65
|
231
|
5l5fE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
68
|
240
|
5l5qC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
59
|
226
|
5l5sH |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
62
|
211
|
5l5eK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
68
|
242
|
5l5qD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
56
|
222
|
5l55H |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
59
|
196
|
5l55N |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
57
|
204
|
5l5qI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
65
|
231
|
5l5dE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
59
|
226
|
5l5fH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
67
|
233
|
5l5hM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
69
|
233
|
5l5pM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
59
|
222
|
5l55L |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
59
|
196
|
5l5pN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
62
|
231
|
5l5eE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
59
|
195
|
5l5qJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
71
|
212
|
5l54K |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
69
|
244
|
5l5qB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
66
|
250
|
5l5pA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
59
|
226
|
5l5eH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
62
|
222
|
5l5qL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone 18 |
69
|
242
|
5l5oD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
59
|
195
|
5l5pJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
58
|
226
|
5l5jH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
64
|
241
|
5l5eG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
58
|
196
|
5l5dN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
68
|
244
|
5l54B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 16 |
70
|
240
|
5l55C |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
67
|
250
|
5l5jA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
58
|
204
|
5l5bI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
67
|
250
|
5l5bA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
62
|
211
|
5l5aK |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
57
|
204
|
5l5fI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
69
|
243
|
5l5oF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
65
|
250
|
5l5iA |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 9 |
69
|
233
|
5l5eM |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
60
|
196
|
5l5bN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
57
|
204
|
5l5hI |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
69
|
240
|
5l5dC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
69
|
243
|
5l5fF |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
61
|
222
|
5l5bL |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
63
|
231
|
5l5hE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |